Business Briefing | HEALTH: Backing for Multiple Sclerosis Drug Lifts Stock
Friday, May 20, 2011 - 21:40
in Mathematics & Economics
Acorda Therapeutics won the backing of European Union regulators for a drug it makes with Biogen Idec to improve walking in multiple sclerosis patients, setting off a 14 percent gain in its share price.